Ormco Announces Sole Distribution of OrthoPulse Gen.2 Medical Device

Ormco Announces Sole Distribution of OrthoPulse Gen.2 Medical Device

Orthodontic product company Ormco^™ has announced that it will be the sole distributor of the OrthoPulse^® generation 2 medical device in the United States. The OrthoPulse device is designed to help patients accelerate orthodontic treatment by using low levels of light energy to stimulate bone and move teeth, according to a press release from Ormco. The second generation OrthoPulse has a variety of improved features over the first generation such as more battery life, a water protectant design for both the charging case and mouthpiece, a more flexible mouthpiece, and an improved mobile application.

“Thanks to the innovative technology of OrthoPulse, my patients can safely and effectively accelerate their orthodontic treatment,” said Ormco customer Dr Jeff Summers in the press release. “OrthoPulse integrates easily into their daily routine, and we are also seeing that it is gentle and comfortable to help reduce pain and discomfort associated with treatment.”

Generation 2 is said to reduce treatment time for braces and clear aligners by up to 50%, and is approved by the United States Food and Drug Administration for all users. Patients can use at home every day for best results. This will be a boon for both patient and practitioner, according to Ormco President Jim McGillivary.

“Through modification of a patient’s biological response to treatment and hence shortening the orthodontic timeline, patients and doctors find this device invaluable which is why we are so excited to announce that Ormco is the sole U.S. Distributor for the latest version of the already popular OrthoPulse device,” said McGillivary in the press release. “Giving fixed and aligner patients more comfort and significantly lessening treatment time while shortening chair time and increasing predictive outcomes are all important aspects of our core business.”